We are live on ! Find out more
CL

CSS LLC Portfolio holdings

AUM $2.09B
1-Year Est. Return 59.56%
This Fund
S&P 500
This Quarter Est. Return
+2.58%
1 Year Est. Return
+59.56%
3 Year Est. Return
+106.78%
5 Year Est. Return
+137.14%
10 Year Est. Return
+420.84%
AUM
$2.13B
AUM Growth
-$326M
Cap. Flow
-$764M
Cap. Flow %
-35.91%
Top 10 Hldgs %
22.61%
Holding
1,396
New
328
Increased
216
Reduced
252
Closed
351
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLT icon
776
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$43.1B
$72K ﹤0.01%
700
-20,100
-97% -$2.26M
FUBO icon
777
PUT
FuboTV Inc
FUBO
$266M
$71K ﹤0.01%
+1,667
New +$71.6K
ARCH
778
PUT
DELISTED
Arch Resources, Inc.
ARCH
$71K ﹤0.01%
600
CARM
779
DELISTED
Carisma Therapeutics
CARM
$70K ﹤0.01%
+8,254
New +$112K
QVCGB
780
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
$70K ﹤0.01%
208
-178
-46% -$76.1K
BHC icon
781
PUT
Bausch Health
BHC
$1.69B
$69K ﹤0.01%
+10,000
New +$69.5K
NVAX icon
782
Novavax
NVAX
$1.21B
$69K ﹤0.01%
3,800
-12,524
-77% -$543K
QVCGA
783
DELISTED
QVC Group Inc Series A
QVCGA
$68K ﹤0.01%
680
EVGOW
784
DELISTED
EVgo Inc Warrants
EVGOW
$66K ﹤0.01%
36,011
-6,000
-14% -$11.7K
SQFTW icon
785
Presidio Property Trust Inc Series A Warrants
SQFTW
$198K
$66K ﹤0.01%
551,573
-16,553
-3% -$2.56K
HIL
786
DELISTED
Hill International, Inc. Common Stock
HIL
$66K ﹤0.01%
+20,000
New +$49.5K
AYLA
787
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$64K ﹤0.01%
64,180
AEF
788
abrdn Emerging Markets Equity Income Fund
AEF
$342M
$63K ﹤0.01%
13,821
LI icon
789
Li Auto
LI
$13.8B
$63K ﹤0.01%
2,744
XERS icon
790
Xeris Biopharma Holdings
XERS
$1.42B
$62K ﹤0.01%
39,831
-27,503
-41% -$45.5K
T icon
791
AT&T
T
$169B
$60K ﹤0.01%
3,871
-3,221
-45% -$58.6K
VMEO
792
PUT
DELISTED
Vimeo
VMEO
$60K ﹤0.01%
+15,000
New +$88.7K
CRDF icon
793
CALL
Cardiff Oncology
CRDF
$63.6M
$59K ﹤0.01%
38,100
-79,400
-68% -$191K
APPH
794
CALL
DELISTED
AppHarvest, Inc. Common Stock
APPH
$59K ﹤0.01%
+30,100
New +$97.4K
RDFN
795
CALL
DELISTED
Redfin
RDFN
$58K ﹤0.01%
+10,000
New +$88.8K
RDFN
796
PUT
DELISTED
Redfin
RDFN
$58K ﹤0.01%
+10,000
New +$88.8K
XELAP
797
DELISTED
Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock
XELAP
$58K ﹤0.01%
11,655
-10,865
-48% -$63.9K
BTAI icon
798
CALL
BioXcel Therapeutics
BTAI
$26.1M
$57K ﹤0.01%
300
-625
-68% -$145K
SIRI icon
799
CALL
SiriusXM
SIRI
$10.7B
$57K ﹤0.01%
1,000
-1,450
-59% -$91.1K
NKLA
800
DELISTED
Nikola Corporation Common Stock
NKLA
$57K ﹤0.01%
540

Similar funds

CSS LLC's Q3 2022 Portfolio in Review

As of Q3 2022, CSS LLC held 1,396 positions worth $2.13B, down 13% from $2.45B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

CSS LLC withdrew a net $764M in Q3 2022, closing 351 positions and reducing 252 holdings. Its most notable exit was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A, an estimated $127M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Energy and Healthcare.

Against the trend, CSS LLC opened a new position in Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In worth $17.4M.

  • CSS LLC's largest Q3 2022 buy was Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In: 85,865 shares worth $17.4M.
  • CSS LLC added most to Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, an estimated $28.3M increase.
  • CSS LLC's biggest Q3 2022 reduction was PG&E Corporation, cutting an estimated $17.3M.
  • CSS LLC fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q3 2022, selling an estimated $127M.
  • CSS LLC's ten largest holdings make up 23% of its $2.13B portfolio in Q3 2022.
  • CSS LLC opened 328 new positions and closed 351 in Q3 2022.
  • CSS LLC's portfolio value fell 13% quarter-over-quarter to $2.13B.

Based on CSS LLC's 13F filing for Q3 2022, filed 14 Nov 2022.